Home  /  Resource Library  /  Similar Efficacy for Axi-cel and Tisa-Cel in Follicular Lymphoma Noted With Match Adjusted Comparison

Similar Efficacy for Axi-cel and Tisa-Cel in Follicular Lymphoma Noted With Match Adjusted Comparison

Transplantation and Cellular Therapy 2022: Match adjusted study compared CAR T therapies axicabtagene ciloleucel and tisagenlecleucel for treatment of relapsed follicular lymphoma.